Tag: Glaxo’s

Posted on

Glaxo’s asthma drug Nucala gets Japanese approval – MarketWatch


Lung Disease News

Glaxo's asthma drug Nucala gets Japanese approval
MarketWatch
The Japanese Ministry of Health, Labour and Welfare granted approval for the drug "as a treatment for bronchial asthma in patients with refractory asthma whose symptoms are inadequately controlled with standard treatment," Glaxo said Tuesday.
FDA Approves Teva's Asthma Drug Cinqair as Add-on TreatmentLung Disease News
GSK: Nucala Receives Approval In Japan For Treatment Of Bronchial AsthmaRTT News
Nucala and Cinqair for the Treatment of Severe AsthmaAbout – News & Issues

all 4 news articles »

View full post on asthma – Google News

Posted on

Glaxo’s Injectable Asthma Treatment ‘Nucala’ Gets Approval From FDA – International Business Times


International Business Times

Glaxo's Injectable Asthma Treatment 'Nucala' Gets Approval From FDA
International Business Times
The U.S. Food and Drug Administration (FDA) has given a go ahead to GlaxoSmithKline Plc's drug Nucala for treatment of severe asthma. The regulato6ry body said that the drug can be used in combination with other therapies and medications for asthma …
FDA Approves New Asthma MedicationSMN Weekly (blog)
Mepolizumab gets green signal from FDA to be used for maintenance treatment of …NYC Today
GlaxoSmithKline plc (ADR): Why Nucala's FDA Approval Is SignificantBidness ETC

all 4 news articles »

View full post on asthma – Google News

Posted on

Glaxos Eosinophilic Asthma Drug Nucala Wins CHMP Backing – Zacks.com


BioPharma Dive

Glaxos Eosinophilic Asthma Drug Nucala Wins CHMP Backing
Zacks.com
In the U.S., the drug is approved for both COPD and asthma. We note that Glaxo has a collaboration agreement with Theravance for Relvar/Breo Ellipta and Anoro Ellipta (COPD). Relvar/Breo Ellipta generated sales of £94 million in the first half of 2015.
After bad news on Breo, Glaxo's monthly asthma drug wins an EU recBioPharma Dive

all 2 news articles »

View full post on asthma – Google News

Posted on

UPDATE: Glaxo’s (GSK) Severe Asthma Drug Mepolizumab Found Effective in … – StreetInsider.com

UPDATE: Glaxo's (GSK) Severe Asthma Drug Mepolizumab Found Effective in …
StreetInsider.com
GlaxoSmithKline (NYSE: GSK) severe asthma drug, mepolizumab, is effective in adults, FDA panel says, according to Bloomberg. UPDATE – Last November, Glaxo announced that it filed regulatory submissions in the USA and Europe for mepolizumab for …

View full post on asthma – Google News

Posted on

FDA staff finds no new safety problems with Glaxo’s asthma drug – Reuters


Reuters

FDA staff finds no new safety problems with Glaxo's asthma drug
Reuters
(Reuters) – GlaxoSmithKline Plc's respiratory treatment for chronic breathing problems did not show any new safety problems while being tested to treat asthma, a preliminary review by U.S. Food and Drug Administration staff found. The review comes two …
Ad Comm meeting approaches for expanded indication for Glaxo's COPD med …Seeking Alpha (registration)

all 5 news articles »

View full post on asthma – Google News

Posted on

FDA staff finds no new safety problems with Glaxo’s asthma drug – Business Insider


Reuters

FDA staff finds no new safety problems with Glaxo's asthma drug
Business Insider
(Reuters) – GlaxoSmithKline Plc's respiratory treatment for chronic breathing problems did not show any new safety problems in treating asthma, a preliminary review by U.S. Food and Drug Administration staff found. The review comes two days ahead of a …
Ad Comm meeting approaches for expanded indication for Glaxo's COPD med …Seeking Alpha (registration)

all 1 news articles »

View full post on asthma – Google News

Posted on

Glaxo’s Experimental Drug Halves Asthma Attacks in Study – Businessweek


Telegraph.co.uk

Glaxo's Experimental Drug Halves Asthma Attacks in Study
Businessweek
Among 621 participants with severe asthma, after a year of treatment, the rate of attacks requiring oral corticosteroids, emergency room visits or hospitalizations was about half for those taking one of three monthly doses of the drug, called …
Experimental Drug May Cut Severe Asthma Attacks: StudyU.S. News & World Report
GSK drug halves attacks in hard-to-treat asthmaChicago Tribune
Experimental drug halves attacks in hard-to-treat asthmaFox News
Telegraph.co.uk
all 34 news articles »

View full post on asthma – Google News